Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome

Recruiting now

Conditions studied: Kidney Failure, Acute

In brief

Evaluation of non-invasive prognostic parameters in patients developing ACLF and renal failure in patients receiving and not receiving transjugular intrahepatic portosystemic shunt (TIPS). Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.

Key facts

Study ID

NCT04446858

Run by

University Hospital, Bonn

People needed

1000

Starts

2021-01-01

Expected to finish

2030-07-01

Last updated by the study team

2022-05-18

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients with portal hypertension and kidney failure

You may not qualify if…

• no consent, no kidney failure, no portal hypertension

Where it is running

• University Hospital Bonn — Bonn, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.